6143—Botulinum toxin type A treatment for Raynaud’s phenomenon: Experience and 3-year follow-up

Introduction: Raynaud's phenomenon consists of vasospastic disease of the digital arteries after exposure to cold or stress and may appear in isolation or in the context of a systemic disease. When severe, it causes an important reduction in a patient's quality of life. The available treatments do not always offer good results, making it necessary to look for therapeutic alternatives.